| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-22 |
4 |
AS |
$15.11 |
$3,188 |
D/D |
(211) |
412,168 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-23 |
4 |
AS |
$15.16 |
$1,546 |
D/D |
(102) |
412,066 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
COO & CSO |
• – – |
2018-02-14 |
4 |
AS |
$15.16 |
$70,418 |
D/D |
(4,645) |
496,045 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-11-23 |
4 |
AS |
$15.20 |
$1,550 |
D/D |
(102) |
358,603 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2017-08-21 |
4 |
AS |
$15.20 |
$12,479 |
D/D |
(821) |
488,421 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-08-24 |
4 |
AS |
$15.22 |
$1,568 |
D/D |
(103) |
341,887 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-11-29 |
4 |
AS |
$15.22 |
$2,770 |
D/D |
(182) |
358,421 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-02-18 |
4 |
A |
$15.37 |
$160,617 |
D/D |
10,450 |
475,586 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-08-15 |
4 |
AS |
$15.43 |
$3,364 |
D/D |
(218) |
425,203 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-08-23 |
4 |
AS |
$15.58 |
$1,589 |
D/D |
(102) |
402,586 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Research |
• – – |
2006-05-03 |
4 |
AS |
$15.60 |
$474,886 |
D/D |
(30,000) |
602,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-05-03 |
4/A |
AS |
$15.60 |
$157,029 |
D/D |
(10,000) |
618,412 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2017-02-22 |
4 |
AS |
$15.60 |
$16,676 |
D/D |
(1,069) |
490,837 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-05-04 |
4/A |
AS |
$15.67 |
$78,619 |
D/D |
(5,000) |
617,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-08-19 |
4 |
AS |
$15.67 |
$3,338 |
D/D |
(213) |
402,688 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-24 |
4 |
AS |
$15.71 |
$12,238 |
D/D |
(779) |
411,287 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-05-05 |
4/A |
AS |
$15.85 |
$239,241 |
D/D |
(15,000) |
602,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-09-01 |
4 |
AS |
$15.90 |
$159,469 |
D/D |
(10,000) |
562,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2017-05-19 |
4 |
AS |
$15.90 |
$13,054 |
D/D |
(821) |
489,629 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
COO & CSO |
• – – |
2018-02-21 |
4 |
AS |
$15.90 |
$11,846 |
D/D |
(745) |
495,300 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2017-05-10 |
4 |
AS |
$16.00 |
$6,144 |
D/D |
(384) |
490,453 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
COO & CSO |
• – – |
2018-02-08 |
4 |
AS |
$16.00 |
$30,672 |
D/D |
(1,917) |
490,928 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-08-26 |
4 |
AS |
$16.07 |
$2,941 |
D/D |
(183) |
402,403 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
COO & CSO |
• – – |
2018-02-12 |
4 |
AS |
$16.20 |
$5,524 |
D/D |
(341) |
500,690 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-08-26 |
4 |
AS |
$16.57 |
$3,016 |
D/D |
(182) |
341,705 |
0 |
- |
|
173 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
